Oruka Therapeutics
ORKA
13 hedge funds and large institutions have $755K invested in Oruka Therapeutics in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
18% more funds holding
Funds holding: 11 → 13 (+2)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
6% less capital invested
Capital invested by funds: $804K → $755K (-$49K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$109K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$24.6K |
| 3 |
OC
Oppenheimer & Co
New York
|
+$23.4K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$8.19K |
| 5 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
+$2.34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$81K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$17.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$11.7K |
| 4 |
Citigroup
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $362K | +$24.6K | +21 | +8% |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $112K | +$109K | +93 | New |
|
|
SKK
3
Shepherd Kaplan Krochuk
Boston,
Massachusetts
| $75K | +$2.34K | +2 | +3% |
|
|
VKH
4
Virtu KCG Holdings
New York
| $63K | -$17.6K | -15 | -22% |
|
5
California Public Employees Retirement System
Sacramento,
California
| $44K | – | – | – |
|
6
Citadel Advisors
Miami,
Florida
| $25K | – | – | – |
|
|
OC
7
Oppenheimer & Co
New York
| $24K | +$23.4K | +20 | New |
|
8
Geode Capital Management
Boston,
Massachusetts
| $20K | – | – | – |
|
9
Bank of America
Charlotte,
North Carolina
| $12K | – | – | – |
|
|
10
HighTower Advisors
Chicago,
Illinois
| $9K | +$8.19K | +7 | New |
|
|
11
UBS Group
Zurich,
Switzerland
| $6K | -$11.7K | -10 | -67% |
|
|
BIM
12
BlackRock Investment Management
Wilmington,
Delaware
| $2K | – | – | – |
|
|
EWM
13
Edge Wealth Management
New York
| $1K | +$1.17K | +1 | New |
|
|
AFM
14
Anson Funds Management
Dallas,
Texas
| – | -$81K | -56 | Closed |
|
|
15
Citigroup
New York
| – | -$1K | -1 | Closed |
|
ORKA Hedge Fund Activity: Q1 2015 in Review
13 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Oruka Therapeutics (ORKA) for Q1 2015, worth a combined $755K — down 6.1% from $804K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ORKA positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $109K. The largest seller was Anson Funds Management, exiting entirely with an estimated $81K sold.
- 13 institutional investors held Oruka Therapeutics (ORKA) as of Q1 2015, up from 11 in Q4 2014.
- Funds reported $755K of Oruka Therapeutics stock for Q1 2015, down 6.1% quarter-over-quarter.
- 4 funds opened new Oruka Therapeutics positions in Q1 2015 and 2 closed out, a net change of +2 holders.
- The largest Oruka Therapeutics buyer in Q1 2015 was Sabby Management, an estimated $109K added.
- The largest Oruka Therapeutics seller in Q1 2015 was Anson Funds Management, an estimated $81K sold.
Based on aggregated 13F filings for Q1 2015.